Carregant...
TP63 isoform expression is linked with distinct clinical outcomes in cancer
BACKGROUND: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder cancer, but reports associating it with clinical outcomes are conflicting. Since TP63 is exp...
Guardat en:
| Publicat a: | EBioMedicine |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953644/ https://ncbi.nlm.nih.gov/pubmed/31927310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.11.022 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|